Please login to the form below

Not currently logged in
Email:
Password:

Ian Read

This page shows the latest Ian Read news and features for those working in and with pharma, biotech and healthcare.

New Pfizer UK leader as Nordkamp moves into European role

New Pfizer UK leader as Nordkamp moves into European role

The changes reflect a wider reorganisation in Pfizer's US headquarters, where Albert Bourla will succeed Ian Read as CEO of Pfizer on 1 January, plus a reshuffle of the

Latest news

  • Reference price bill tabled in US House and Senate Reference price bill tabled in US House and Senate

    Pfizer CEO Ian Read said when announcing the increases that “the best means to address affordability of medicines is to reduce the growing out-of-pocket costs that consumers are facing ... Ian Read, Pfizer CEO. There’s a gulf between the tabling of a

  • Is AstraZeneca looking for its next CEO? Is AstraZeneca looking for its next CEO?

    If Soriot does want to move on, there aren’t likely to be many vacancies in big pharma any time soon: Pfizer has just announced that Albert Bourla will succeed Ian ... Read as CEO, and Merck &Co have just changed their rules to allow Ken Frazier to

  • New Pfizer boss shakes up leadership team New Pfizer boss shakes up leadership team

    Albert Bourla, incoming Pfizer CEO. Bourla was revealed as CEO less than two weeks ago, after current boss Ian Read announced he would step down from the role after eight years ... Bourla said: “We are at a pivotal moment in Pfizer’s history, with

  • Pfizer names next CEO as Read retires Pfizer names next CEO as Read retires

    The company’s board of directors unanimously elected Dr. Albert Bourla, Pfizer's current Chief Operating Officer (COO), to succeed Ian Read as CEO from 1 January, 2019. ... Ian Read has been at the helm since December 2010, and will now move into the

  • AstraZeneca chief on Brexit: “It’s going to be really painful” AstraZeneca chief on Brexit: “It’s going to be really painful”

    footing. Yet despite the turnaround he has faced two shareholder revolts over renumeration  and his pay lags behind those of other CEOs such as Pfizer’s Ian Read and Gilead’s

More from news
Approximately 1 fully matching, plus 52 partially matching documents found.

Latest Intelligence

  • The handover: Pfizer reshapes itself for a new era The handover: Pfizer reshapes itself for a new era

    Bourla was revealed as CEO in early October, after current boss Ian Read announced he would step down from the role after eight years of service. ... Bourla said: “We are at a pivotal moment in Pfizer’s history, with Ian Read having positioned the

  • Pharma deals continue to slide Pharma deals continue to slide

    At the beginning of the month this was confirmed by Ian Read, CEO of Pfizer. ... During the second quarter earnings call Read said: “We look at BD (business development) as a way of improving returns for shareholders.

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest appointments

  • Pfizer names Albert Bourla as COO Pfizer names Albert Bourla as COO

    vaccines. Ian Read, chairman and CEO, Pfizer, said: “Albert is a proven and trusted leader with over two decades of leadership experience and a demonstrated track record for delivering strong business

  • Pfizer strengthens board of directors Pfizer strengthens board of directors

    Ian Read, Pfizer's chairman and chief executive officer, said: “We are pleased to welcome Ron Blaylock to Pfizer's board of directors.

  • IFPMA appoints director general IFPMA appoints director general

    Ian Read, IFPMA's president and chief executive and chairman of Pfizer, said: “Thomas has extensive experience in the research-based biopharmaceutical industry and a deep understanding of what is needed

  • IFPMA elects Pfizer’s Ian Read as president IFPMA elects Pfizer’s Ian Read as president

    Read succeeds Merck KGaA’s Dr Stefan Oschmann for a two-year term. ... The International Federation of Pharmaceutical Manufacturers &Associations (IFPMA) has elected Pfizer's Ian Read as its new president, succeeding Merck KGaA's Dr Stefan Oschmann.

  • Adobe CEO joins Pfizer board Adobe CEO joins Pfizer board

    The addition of Shantanu Narayen to our board helps ensure that Pfizer will continue to benefit from a diversity of experience,” said Ian Read, Pfizer's chairman and CEO.

More from appointments
Approximately 0 fully matching, plus 6 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Random42 Scientific Communication

Random42 is the world's leading medical animation company. Over the past 25 years we have produced core digital assets for...

Latest intelligence

2019: CRISPR and therapeutic gene editing comes of age
Can gene-editing deliver safe and effective therapeutics for patients with intractable diseases?...
The 10-year Web Challenge
Understanding your users’ needs is more critical online today than ever. A site should mould itself around these insights, deliver those needs quickly, efficiently and with plenty of white space....
Downloadable Pack: Understanding Multiple Sclerosis
Inside this downloadable pack, you’ll find a wealth of exclusive information on the way multiple sclerosis is commonly treated today. As well as areas of continuous improvement for the industry....

Infographics